The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase I/II study of lenvatinib (LEN) plus everolimus (EVE) in recurrent and refractory pediatric solid tumors, including CNS tumors.
 
Filemon S. Dela Cruz
No Relationships to Disclose
 
Elizabeth Fox
Research Funding - Ignyta (Inst); Novartis (Inst)
Other Relationship - Helsinn Therapeutics
 
Jodi Ann Muscal
Consulting or Advisory Role - Bayer
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Eisai (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Oncternal Therapeutics (Inst); Pfizer (Inst); Synergene (Inst); Takeda (Inst); Teva (Inst)
Travel, Accommodations, Expenses - Lilly
 
Ivan Kirov
No Relationships to Disclose
 
James I. Geller
Travel, Accommodations, Expenses - Fennec Pharma
 
Steven G. DuBois
Research Funding - Bayer (Inst); Bristol-Myers Squibb (Inst); Curis (Inst); Eisai (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Pfizer (Inst); Roche/Genentech (Inst); Salarius Pharmaceuticals (Inst); Turning Point Therapeutics (Inst)
Travel, Accommodations, Expenses - Roche/Genentech; Salarius Pharmaceuticals
(OPTIONAL) Uncompensated Relationships - Ymabs Therapeutics Inc
 
AeRang Kim
No Relationships to Disclose
 
James Croop
Research Funding - Amgen
Travel, Accommodations, Expenses - Bayer
 
Theodore Willis Laetsch
Consulting or Advisory Role - Bayer; Lilly; Loxo; Novartis
Research Funding - Abbvie (Inst); Amgen (Inst); Atara Biotherapeutics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Epizyme (Inst); GlaxoSmithKline (Inst); Janssen (Inst); Jubilant Pharmaceuticals (Inst); Lilly (Inst); Loxo (Inst); Novartis (Inst); Novella Clinical (Inst); Pfizer (Inst); SERVIER (Inst)
 
Charles G. Minard
No Relationships to Disclose
 
Xiaowei Liu
No Relationships to Disclose
 
Brenda Weigel
Travel, Accommodations, Expenses - Genentech; Lilly/ImClone; Nektar; Roche/Genentech; Roche/Genentech
 
Chinyere E. Okpara
Employment - Eisai
 
Jie Huang
Employment - Eisai
 
Lea Dutta
Employment - Eisai
Research Funding - Eisai
 
Jagadeesh Aluri
Employment - Eisai
 
Julia Lynne Glade Bender
Consulting or Advisory Role - Abbvie (Inst)
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Celgene (Inst); Eisai (Inst); Ignyta (Inst); Lilly (Inst); Loxo (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Amgen; Bayer; Merck; Novartis; Roche/Genentech
(OPTIONAL) Uncompensated Relationships - Bristol-Myers Squibb; SpringWorks Therapeutics